Global Circulating Tumor Cells Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Circulating Tumor Cells market size will reach 3,041.60 Million USD in 2025 and is projected to reach 11,820.42 Million USD by 2032, with a CAGR of 21.40% (2025-2032). Notably, the China Circulating Tumor Cells market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Circulating Tumor Cells (CTCs) are rare cancer cells that have detached from a solid tumor and entered the bloodstream, allowing them to circulate throughout the body. These cells play a significant role in cancer metastasis, as they can potentially seed new tumors in distant organs. CTCs can be isolated from a patient's blood sample and analyzed to provide valuable information about the cancer's progression, prognosis, and response to treatment. Detecting and analyzing CTCs is a non-invasive method that can help oncologists monitor disease progression and treatment effectiveness, and it may also guide treatment decisions for personalized therapies. While CTCs are a promising avenue for cancer research and personalized medicine, their rarity and heterogeneity pose challenges in their isolation and analysis. Nonetheless, ongoing advancements in technology and research are making CTC analysis increasingly important in cancer diagnosis and management.
The major global suppliers of Circulating Tumor Cells include Menarini-Silicon Biosystems, Qiagen (Adnagen), Advanced Cell Diagnostics, ApoCell, Epic Sciences, Greiner Bio-one GmbH, Cynvenio, SurExamBio-Tech, Fluxion Biosciences, Ikonisys, Hangzhou Watson Biotech, Biocept, Guangzhou Wondfo Biotech, CytoTrack, Celsee, ANGLE plc, Clearbridge Biomedics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Circulating Tumor Cells. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Circulating Tumor Cells market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Circulating Tumor Cells market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Circulating Tumor Cells industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Circulating Tumor Cells Include:
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
Guangzhou Wondfo Biotech
CytoTrack
Celsee
ANGLE plc
Clearbridge Biomedics
Circulating Tumor Cells Product Segment Include:
CTC Enrichment
CTC Detection
CTC Analysis
Circulating Tumor Cells Product Application Include:
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Circulating Tumor Cells Industry PESTEL Analysis
Chapter 3: Global Circulating Tumor Cells Industry Porter's Five Forces Analysis
Chapter 4: Global Circulating Tumor Cells Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Circulating Tumor Cells Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Circulating Tumor Cells Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Circulating Tumor Cells Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Circulating Tumor Cells market size will reach 3,041.60 Million USD in 2025 and is projected to reach 11,820.42 Million USD by 2032, with a CAGR of 21.40% (2025-2032). Notably, the China Circulating Tumor Cells market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Circulating Tumor Cells (CTCs) are rare cancer cells that have detached from a solid tumor and entered the bloodstream, allowing them to circulate throughout the body. These cells play a significant role in cancer metastasis, as they can potentially seed new tumors in distant organs. CTCs can be isolated from a patient's blood sample and analyzed to provide valuable information about the cancer's progression, prognosis, and response to treatment. Detecting and analyzing CTCs is a non-invasive method that can help oncologists monitor disease progression and treatment effectiveness, and it may also guide treatment decisions for personalized therapies. While CTCs are a promising avenue for cancer research and personalized medicine, their rarity and heterogeneity pose challenges in their isolation and analysis. Nonetheless, ongoing advancements in technology and research are making CTC analysis increasingly important in cancer diagnosis and management.
The major global suppliers of Circulating Tumor Cells include Menarini-Silicon Biosystems, Qiagen (Adnagen), Advanced Cell Diagnostics, ApoCell, Epic Sciences, Greiner Bio-one GmbH, Cynvenio, SurExamBio-Tech, Fluxion Biosciences, Ikonisys, Hangzhou Watson Biotech, Biocept, Guangzhou Wondfo Biotech, CytoTrack, Celsee, ANGLE plc, Clearbridge Biomedics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Circulating Tumor Cells. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Circulating Tumor Cells market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Circulating Tumor Cells market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Circulating Tumor Cells industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Circulating Tumor Cells Include:
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
Guangzhou Wondfo Biotech
CytoTrack
Celsee
ANGLE plc
Clearbridge Biomedics
Circulating Tumor Cells Product Segment Include:
CTC Enrichment
CTC Detection
CTC Analysis
Circulating Tumor Cells Product Application Include:
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Circulating Tumor Cells Industry PESTEL Analysis
Chapter 3: Global Circulating Tumor Cells Industry Porter's Five Forces Analysis
Chapter 4: Global Circulating Tumor Cells Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Circulating Tumor Cells Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Circulating Tumor Cells Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Circulating Tumor Cells Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Circulating Tumor Cells Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Circulating Tumor Cells Product by Type
- 1.2.1 CTC Enrichment
- 1.2.2 CTC Detection
- 1.2.3 CTC Analysis
- 1.3 Circulating Tumor Cells Product by Application
- 1.3.1 Breast Cancer
- 1.3.2 Prostate Cancer
- 1.3.3 Colorectal Cancer
- 1.3.4 Lung Cancer
- 1.3.5 Others
- 1.4 Global Circulating Tumor Cells Market Size Analysis (2020-2032)
- 1.5 Circulating Tumor Cells Market Development Status and Trends
- 1.5.1 Circulating Tumor Cells Industry Development Status Analysis
- 1.5.2 Circulating Tumor Cells Industry Development Trends Analysis
- 2 Circulating Tumor Cells Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Circulating Tumor Cells Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Circulating Tumor Cells Market Analysis by Country
- 4.1 Global Circulating Tumor Cells Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Circulating Tumor Cells Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Circulating Tumor Cells Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.5 China Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.6 France Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.14 India Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Circulating Tumor Cells Market Revenue by Key Suppliers (2021-2025)
- 5.2 Circulating Tumor Cells Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Circulating Tumor Cells Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Circulating Tumor Cells Market Analysis by Type
- 6.1 Global Circulating Tumor Cells Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Circulating Tumor Cells Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Menarini-Silicon Biosystems
- 7.1.1 Menarini-Silicon Biosystems Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Menarini-Silicon Biosystems Circulating Tumor Cells Product Portfolio
- 7.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Qiagen (Adnagen)
- 7.2.1 Qiagen (Adnagen) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Qiagen (Adnagen) Circulating Tumor Cells Product Portfolio
- 7.2.3 Qiagen (Adnagen) Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Advanced Cell Diagnostics
- 7.3.1 Advanced Cell Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Advanced Cell Diagnostics Circulating Tumor Cells Product Portfolio
- 7.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 ApoCell
- 7.4.1 ApoCell Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 ApoCell Circulating Tumor Cells Product Portfolio
- 7.4.3 ApoCell Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Epic Sciences
- 7.5.1 Epic Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Epic Sciences Circulating Tumor Cells Product Portfolio
- 7.5.3 Epic Sciences Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Greiner Bio-one GmbH
- 7.6.1 Greiner Bio-one GmbH Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Greiner Bio-one GmbH Circulating Tumor Cells Product Portfolio
- 7.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Cynvenio
- 7.7.1 Cynvenio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Cynvenio Circulating Tumor Cells Product Portfolio
- 7.7.3 Cynvenio Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 SurExamBio-Tech
- 7.8.1 SurExamBio-Tech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 SurExamBio-Tech Circulating Tumor Cells Product Portfolio
- 7.8.3 SurExamBio-Tech Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Fluxion Biosciences
- 7.9.1 Fluxion Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Fluxion Biosciences Circulating Tumor Cells Product Portfolio
- 7.9.3 Fluxion Biosciences Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Ikonisys
- 7.10.1 Ikonisys Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Ikonisys Circulating Tumor Cells Product Portfolio
- 7.10.3 Ikonisys Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Hangzhou Watson Biotech
- 7.11.1 Hangzhou Watson Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Hangzhou Watson Biotech Circulating Tumor Cells Product Portfolio
- 7.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Biocept
- 7.12.1 Biocept Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Biocept Circulating Tumor Cells Product Portfolio
- 7.12.3 Biocept Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Guangzhou Wondfo Biotech
- 7.13.1 Guangzhou Wondfo Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Guangzhou Wondfo Biotech Circulating Tumor Cells Product Portfolio
- 7.13.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 CytoTrack
- 7.14.1 CytoTrack Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 CytoTrack Circulating Tumor Cells Product Portfolio
- 7.14.3 CytoTrack Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Celsee
- 7.15.1 Celsee Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Celsee Circulating Tumor Cells Product Portfolio
- 7.15.3 Celsee Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.16 ANGLE plc
- 7.16.1 ANGLE plc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.16.2 ANGLE plc Circulating Tumor Cells Product Portfolio
- 7.16.3 ANGLE plc Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.17 Clearbridge Biomedics
- 7.17.1 Clearbridge Biomedics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.17.2 Clearbridge Biomedics Circulating Tumor Cells Product Portfolio
- 7.17.3 Clearbridge Biomedics Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Circulating Tumor Cells Industry Chain Analysis
- 8.2 Circulating Tumor Cells Product Downstream Application Analysis
- 8.2.1 Global Circulating Tumor Cells Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Circulating Tumor Cells Revenue and Forecast by Application (2020-2032)
- 8.3 Circulating Tumor Cells Typical Downstream Customers
- 8.4 Circulating Tumor Cells Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
